FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmacology and represents the use of a composition containing a lipid, protein and split carbohydrate component with the protein component produced of cow's milk protein providing at least 9% of total energy, with the lipid component providing 35 to 55% of total energy, and with the split carbohydrate component containing at least 35 wt % of lactose and providing 30 to 60 % of total energy, for making the food composition to be introduced in a human under the age of 36 months and for a) preventing and/or treating visceral obesity; b) preventing and/or treating excessive accumulation of visceral fat tissue; and/or c) decreased ratio of visceral fatty tissue to subcutaneous fat.
EFFECT: reduced accumulation of visceral fat.
11 cl, 4 ex, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
NUTRITIONAL COMPOSITION INTENDED FOR PREVENTION OF BABY ADIPOSITY | 2006 |
|
RU2417712C2 |
APPLICATION OF NUTRITIVE COMPOSITIONS FOR DISEASES PREVENTION | 2007 |
|
RU2444912C2 |
BABY NUTRITIONAL COMPOSITIONS INTENDED FOR PREVENTION OF ADIPOSITY | 2006 |
|
RU2444210C2 |
APPLICATION OF NUTRIENT COMPOSITIONS WITH PHOSPHOLIPIDS, SPHINGOLIPIDS AND CHOLESTEROL | 2006 |
|
RU2414905C2 |
SYNBIOTIC COMPOSITION FOR PREVENTION OF METABOLIC DISORDERS | 2018 |
|
RU2771716C2 |
NUTRITIONAL COMPOSITIONS WITH LIPID GLOBULES WITH CORE CONTAINING VEGETAL FATS AND WITH COATING CONTAINING PHOPHOLIPIDS OR POLAR LIPIDS | 2009 |
|
RU2497388C2 |
SYNBIOTIC COMPOSITION FOR DISORDER PREVENTION | 2018 |
|
RU2773458C2 |
SYMBIOTIC COMPOSITION FOR PREVENTION OF METABOLIC DISORDERS | 2018 |
|
RU2771744C2 |
EFFECT ON METABOLIC IMPRINTING OF SPECIALLY DEVELOPED LIPID COMPONENT | 2012 |
|
RU2591716C2 |
EFFECTS OF METABOLIC IMPRINTING OF SPECIALLY DESIGNED LIPID COMPONENT | 2012 |
|
RU2586930C2 |
Authors
Dates
2012-04-10—Published
2007-04-19—Filed